Aspen Aerogels (NYSE:ASPN) Price Target Raised to $29.00

Aspen Aerogels (NYSE:ASPN) had its target price increased by Piper Sandler from $20.00 to $29.00 in a research report report published on Friday, Benzinga reports. The firm currently has an overweight rating on the construction company’s stock.

A number of other brokerages also recently commented on ASPN. HC Wainwright raised their price objective on Aspen Aerogels from $20.00 to $25.00 and gave the stock a buy rating in a research report on Friday. TheStreet upgraded shares of Aspen Aerogels from a d+ rating to a c- rating in a research note on Wednesday, March 6th. Finally, Roth Mkm restated a buy rating and issued a $22.00 price objective on shares of Aspen Aerogels in a research note on Tuesday, April 30th. One analyst has rated the stock with a sell rating and six have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of Moderate Buy and a consensus target price of $25.17.

Aspen Aerogels Stock Up 5.3 %

Shares of ASPN stock opened at $25.11 on Friday. The stock has a 50 day moving average of $16.72 and a 200-day moving average of $13.77. The firm has a market cap of $1.93 billion, a PE ratio of -57.07 and a beta of 1.97. The company has a quick ratio of 2.91, a current ratio of 3.41 and a debt-to-equity ratio of 0.24. Aspen Aerogels has a 12 month low of $5.32 and a 12 month high of $25.65.

Aspen Aerogels (NYSE:ASPN) last posted its quarterly earnings results on Tuesday, February 13th. The construction company reported ($0.01) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.12) by $0.11. Aspen Aerogels had a negative net margin of 10.73% and a negative return on equity of 6.54%. The company had revenue of $84.22 million for the quarter, compared to analyst estimates of $83.82 million. During the same period last year, the business posted ($0.20) EPS. On average, equities analysts predict that Aspen Aerogels will post 0.03 EPS for the current year.

Institutional Investors Weigh In On Aspen Aerogels

Institutional investors and hedge funds have recently made changes to their positions in the company. AIGH Capital Management LLC bought a new position in Aspen Aerogels during the 3rd quarter valued at about $15,067,000. Mesirow Institutional Investment Management Inc. bought a new position in Aspen Aerogels in the 4th quarter valued at $12,015,000. Rice Hall James & Associates LLC boosted its stake in Aspen Aerogels by 385.0% in the third quarter. Rice Hall James & Associates LLC now owns 623,135 shares of the construction company’s stock worth $5,359,000 after purchasing an additional 494,662 shares in the last quarter. Worth Venture Partners LLC bought a new stake in shares of Aspen Aerogels during the third quarter worth $3,684,000. Finally, Federated Hermes Inc. grew its holdings in shares of Aspen Aerogels by 53.9% during the fourth quarter. Federated Hermes Inc. now owns 1,154,042 shares of the construction company’s stock worth $18,211,000 after purchasing an additional 404,042 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.